Erratum: KI Editors’ expression of concern about organ source in transplantation papers (Kidney International (2011) 79(6) (655–662), (S0085253815548461), (10.1038/ki.2010.437));De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection

Kidney International

Volumn 79, Issue 6, 2011, Pages 655-662

  Sun, Qiquan ^a   Cheng, Zhen ^a   Cheng, Dongrui ^a   Chen, Jinsong ^a   Ji, Shuming ^a   Wen, Jiqiu ^a   Zheng, Chunxia ^a   Liu, Zhihong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

acute rejection; renal transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; COMPLEMENT COMPONENT C4D; CYCLOSPORIN A; CYTOKINE ANTIBODY; DACLIZUMAB; ENDOTHELIAL CELL ANTIBODY; INTERLEUKIN 2 ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY PRODUCTION; ARTICLE; COMPLEMENT DEPOSITION; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; GLOMERULITIS; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOADSORPTION; IMMUNOPATHOGENESIS; INCIDENCE; INFLAMMATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RISK FACTOR;

EID: 79952177463     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2019.07.011     Document Type: Erratum

References (39)

1. Zou Y, Stastny P, Susal C et al. Antibodies against MICA antigens and kidney-transplant (Pubitemid 47481451)
2. Dragun D, Muller DN, Brasen JH et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558-569. (Pubitemid 40204669)
3. Sis B, Jhangri GS, Bunnag S et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312-2323.
4. Breimer ME, Rydberg L, Jackson AM et al. Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation. Transplantation 2009; 87: 549-556.
5. Cerilli J, Brasile L, Galouzis T et al. The vascular endothelial cell antigen system. Transplantation 1985; 39: 286-289. (Pubitemid 15137826)
6. Paul LC, Baldwin III WM, van Es LA. Vascular endothelial alloantigens in renal transplantation. Transplantation 1985; 40: 117-123. (Pubitemid 15007309)
7. Sun Q, Liu Z, Yin G et al. Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases. Transplantation 2005; 79: 1759-1762. (Pubitemid 40885278)
8. Sun Q, Liu Z, Chen J et al. Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection. Clin J Am Soc Nephrol 2008; 3: 1479-1486.
9. Glotz D, Lucchiari N, Pegaz-Fiornet B et al. Endothelial cells as targets of allograft rejection. Transplantation 2006; 82: S19-S21. (Pubitemid 44035980)
10. Ferry BL, Welsh KI, Dunn MJ et al. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection. Transpl Immunol 1997; 5: 17-24. (Pubitemid 27143937)
11. Jordan SC, Yap HK, Sakai RS et al. Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch. Transplantation 1988; 46: 585-587.
12. Perrey C, Brenchley PE, Johnson RW et al. An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol 1998; 6: 101-106. (Pubitemid 28454332)
13. Sumitran-Karuppan S, Tyden G, Reinholt F et al. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997; 5: 321-327. (Pubitemid 28026578)
14. Grandtnerova B, Mackova N, Hovoricova B et al. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports. Transplant Proc 2008; 40: 2422-2424.
15. Alvarez-Marquez A, Aguilera I, Blanco RM et al. Positive association of anticytoskeletal endothelial cell antibodies and cardiac allograft rejection. Hum Immunol 2008; 69: 143-148.
16. Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714. (Pubitemid 36745243)
17. Fredrich R, Toyoda M, Czer LS et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 1999; 67: 385-391. (Pubitemid 29094008)
18. Toyoda M, Petrosian A, Jordan SC. Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection. Transplantation 1999; 68: 1311-1318.
19. Pober JS, Orosz CG, Rose ML et al. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61: 343-349.
20. Smith JD, Crisp SJ, Dunn MJ et al. Pre-transplant anti-epithelial cell antibodies and graft failure after single lung transplantation. Transpl Immunol 1995; 3: 68-73.
21. Rose ML, Smith JD, Lawson C. Antibody formation and its impact on longterm graft outcome. Transplant Proc 2001; 33: 2411-2413. (Pubitemid 33762757)
22. Le Bas-Bernardet S, Hourmant M, Coupel S et al. Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 2003; 3: 167-177. (Pubitemid 36323114)
23. Ismail AM, Badawi RM, El-Agroudy AE et al. Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome. Exp Clin Transplant 2009; 7: 104-109.
24. Han F, Lv R, Jin J et al. Pre-transplant serum concentrations of antiendothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection. Clin Chem Lab Med 2009; 47: 1265-1269.
25. Costa C, Touscoz GA, Bergallo M et al. Non-organ-specific and antiendothelial antibodies in relation to CMV infection and acute rejection in renal transplant recipients. Clin Transplant 2010; 24: 488-492.
26. Nakagawa Y, Saito K, Morioka T et al. The clinical significance of antibody to vascular endothelial cells after renal transplantation. Clin Transplant 2002; 16(Suppl 8): 51-57. (Pubitemid 41185574)
27. Youinou P. New target antigens for anti-endothelial cell antibodies. Immunobiology 2005; 210: 789-797. (Pubitemid 41683864)
28. O'Donnell J, Mille-Baker B, Laffan M. Human umbilical vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens. J Vasc Res 2000; 37: 540-547. (Pubitemid 32037629)
29. Belizna C, Tervaert JW. Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. Semin Arthritis Rheum 1997; 27: 98-109. (Pubitemid 27461155)
30. Ronda N, Meroni PL, Raschi E et al. Anti-endothelial cell autoantibodies. In: Shoenfeld Y, Gershwin ME, Meroni PL (eds). Autoantibodies, 2nd edn. Elsevier: Amsterdam, The Netherlands, 2006.
31. Sun Q, Liu ZH, Yin G et al. Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients. Nephrol Dial Transplant 2006; 21: 510-517. (Pubitemid 43160010)
32. Sun Q, Liu ZH, Ji S et al. Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation. Kidney Int 2006; 70: 377-383. (Pubitemid 44086589)
33. Sun Q, Liu ZH, Cheng Z et al. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil. Kidney Int 2007; 71: 24-30. (Pubitemid 44967730)
34. Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010; 15: 42-48.
35. Gartner V, Eigentler TK, Viebahn R. Plasma cell-rich rejection processes in renal transplantation: morphology and prognostic relevance. Transplantation 2006; 81: 986-991. (Pubitemid 43670430)
36. Meehan SM, Domer P, Josephson M et al. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 2001; 32: 205-215. (Pubitemid 32193719)
37. Pei R, Wang G, Tarsitani C et al. Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 1998; 59: 313-322. (Pubitemid 28225990)
38. Takemoto SK, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033-1041. (Pubitemid 38868592)
39. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723. (Pubitemid 29082898)